Topiroxostat, pertuzumab get preliminary Japan nod

02:35 EDT 9 May 2013 | SCRIP

Sanwa Kagaku's gout drug topiroxostat (SK-0910) has received its first approval recommendation worldwide, in Japan for the treatment of hyperuricemia (high blood uric acid) associated with the disease. Chugai/Genentech/Roche's HER-dimerization.....

Original Article: Topiroxostat, pertuzumab get preliminary Japan nod

NEXT ARTICLE

More From BioPortfolio on "Topiroxostat, pertuzumab get preliminary Japan nod"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Rheumatology
Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...

Advertisement